CRITERIA TO SELL
- Must be a US-based, Licensed 503A or 503B Pharmacy (with or without retail pharmacy business)
- Compounding Revenue >1.5M and EBITDA >250K.
- Legal compliance and proper licensing.
- Quality assurance and adherence to manufacturing standards.
- Diverse product range covering relevant therapeutic areas.
- Reliable supply chain and inventory management.
- Competitive pricing for pharmaceutical products.
- Strong customer service and patient care.
- Digital integration for seamless communication and record-keeping.
- Ethical standards and integrity in operations.
- Willingness to collaborate and establish a partnership.
Note: Contact Revelation Pharma for specific criteria and details.
EXPLORE SELLING OPTIONS
The acquisition of either a 503A or 503B pharmacy—or just the compounding book of business—by Revelation Pharma demonstrates a comprehensive approach to expanding access to high-quality, customized medications. Whether selling an entire pharmacy or just the book of business, this presents an opportunity to contribute to a broader network that offers diverse compounded medications while maintaining strict regulatory compliance.
SELLER BENEFITS
EXIT OPPORTUNITY
Providing liquidity and personal financial diversification
SUCCESSION PLANNING
Ensure seamless transition for aging owners looking to retire
ATTRACTIVE ONGOING INVESTMENT
Opportunity to invest in and be part of a high-growth business
CROSS-SELLING OPPORTUNITIES
Pursuing growth in new product segments across key markets
STREAMLINE BACK OFFICE OPERATIONS
Modernized and efficient back office systems, including
Regulatory, IT, HR, Accounting, Marketing, and Legal operations
COLLABORATION
Innovate and share best practices with other industry leaders to
develop and commercialize new treatments to improve patient’s
quality of life
INTER-STATE DISTRIBUTION SOLUTION
Revelation Pharma will address challenges from new regulations
(such as the FDA MOU) through a national team and streamlined
protocols to manage changing regulations (i.e. certification,
licensing, ect.)
BEST IN CLASS COMPLIANCE PROGRAM
Keen focus on addressing the increasing compliance burden
through
• Capex investments to meet regulatory requirements
• Expert business, compliance, and legal teams to address any issues that arise
REVELATION PHARMA IS A NATIONAL NETWORK OF 503A AND 503B COMPOUNDING PHARMACIES PROVIDING INNOVATIVE AND QUALITY PHARMACY PREPARATIONS AND SERVICES THROUGH "INDUSTRY BEST" PATIENT CARE AND SOLUTIONS FOR CUSTOMERS.
